A team led by Nobel Prize-winning scientist David Baker has used an artificial intelligence tool to create new functional antibodies in a breakthrough that could speed up drug development using the cutting-edge technology.
In a study published on Wednesday in Nature, researchers at the University of Washington showed how a generative AI model could be used to design entirely new antibodies — proteins that our immune systems produce to block infections — from scratch.
The pharmaceutical industry widely uses antibodies to create drugs, such as for cancer and coronaviruses. But creating the proteins using computers has been a long-standing challenge in drug design.
您已閱讀22%（670字），剩余78%（2378字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。